ARSKX
Price
$67.31
Change
+$0.20 (+0.30%)
Updated
May 13 closing price
Net Assets
23.27M
VFINX
Price
$543.78
Change
+$3.92 (+0.73%)
Updated
May 13 closing price
Net Assets
1.33T
Ad is loading...

ARSKX vs VFINX

Header iconARSKX vs VFINX Comparison
Open Charts ARSKX vs VFINXBanner chart's image
Archer Stock
Price$67.31
Change+$0.20 (+0.30%)
VolumeN/A
Net Assets23.27M
Vanguard 500 Index Investor
Price$543.78
Change+$3.92 (+0.73%)
VolumeN/A
Net Assets1.33T
ARSKX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARSKX vs. VFINX commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSKX is a Buy and VFINX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.34T vs. ARSKX (23.3M). VFINX pays higher dividends than ARSKX: VFINX (1.25) vs ARSKX (0.18). ARSKX was incepted earlier than VFINX: ARSKX (14 years) vs VFINX (49 years). ARSKX (1.40) is less costly to investors than VFINX (0.14). ARSKX is a more actively managed with annual turnover of: 8.56 vs. VFINX (2.00). VFINX has a lower initial minimum investment than ARSKX: VFINX (0) vs ARSKX (2500). VFINX annual gain was more profitable for investors over the last year : 11.96 vs. ARSKX (-4.48). VFINX return over 5 years is better than : 104.79 vs. ARSKX (52.28).
ARSKXVFINXARSKX / VFINX
Total Expense Ratio1.160.14829%
Annual Report Gross Expense Ratio1.400.141,000%
Fund Existence14 years49 years-
Gain YTD-0.710-0.536132%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.3M1.34T0%
Annual Yield % from dividends0.181.2515%
Returns for 1 year-4.4811.96-37%
Returns for 3 years15.9245.2635%
Returns for 5 years52.28104.7950%
Returns for 10 years52.40175.4930%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRCC6.15-0.04
-0.65%
Monroe Capital Corp
DGX174.49-1.41
-0.80%
Quest Diagnostics
ACAD17.20-0.32
-1.83%
ACADIA Pharmaceuticals
CARM0.19-0.01
-3.73%
Carisma Therapeutics
RCKT6.61-0.38
-5.50%
Rocket Pharmaceuticals